Year archive

Lyka Labs Ltd. — 2022 filings

All 141 regulatory filings released by Lyka Labs Ltd. (LYKALABS) in 2022, sourced directly from the official regulator.

141 Filings

2022 Period

2022 filings (141)

Filing	Released	Lang
Trading Window Regulatory Filings	2022-12-30	English
Pursuant to the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015; the trading window for dealing in securities of the Company shall remain closed with effect from 1st January .... Regulatory Filings	2022-12-30	English
Loss of Share Certificates Regulatory Filings	2022-12-26	English
Loss of Share Certificates Regulatory Filings	2022-12-26	English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has received an intimation from M/s. Link Intime India Private .... Regulatory Filings	2022-12-26	English
Updates Regulatory Filings	2022-12-21	English
Please refer to our earlier communication dated 9th November 2022, with reference to the proposed acquisition of animal healthcare business from Agilis Healthcare Private Limited. Now .... Regulatory Filings	2022-12-21	English
General updates Regulatory Filings	2022-11-29	English
The SEBI Appellate Tribunal, Mumbai Bench; wide its order dated 23rd November 2022, (received by the Company on 29th November 2022) has reduced the debarment period of the Company, from .... Regulatory Filings	2022-11-29	English
Loss of share certificate Regulatory Filings	2022-11-24	English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; we wish to inform you that the Company has issued duplicates share certificates Regulatory Filings	2022-11-24	English
Related Party Transaction Regulatory Filings	2022-11-23	English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; please find enclosed herewith the disclosure on Related Party Transactions .... Regulatory Filings	2022-11-23	English
The Standalone and Consolidated Unaudited Financial Results for the quarter and the half year ended 30th September 2022 Regulatory Filings	2022-11-09	English
Outcome of Board Meeting Regulatory Filings	2022-11-09	English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulation, 2015; the Board of Directors in its meeting held today i. e.9th November 2022 considered .... Regulatory Filings	2022-11-09	English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve We wish to inform you that the meeting .... Regulatory Filings	2022-11-01	English
Board Meeting — Financial results/Other business matters Regulatory Filings	2022-11-01	English
General updates Regulatory Filings	2022-10-12	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30th September, 2022 received from M/s .... Regulatory Filings	2022-10-12	English
I, Kunal N Gandhi S/o Late Shri. Narendra I Gandhi, Promoter/Promoter Group of Lyka Labs Limited; file herewith Form C for Disclosure under Regulation 7 (2) read with Regulation 6 (2) .... Regulatory Filings	2022-10-11	English
Insider Trading - Others Regulatory Filings	2022-10-11	English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company has received an intimation from M/s Link .... Regulatory Filings	2022-10-11	English
Loss of share certificate Regulatory Filings	2022-10-11	English
Postal Ballot Regulatory Filings	2022-10-10	English
With reference to e-postal ballot process undertaken by Lyka Labs Limited for seeking approval of the Members for - 1. Sale of land at Dharampur, Valsad and premises situated at Shivshakti .... Regulatory Filings	2022-10-08	English
Closure of trading window Regulatory Filings	2022-09-30	English
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider .... Regulatory Filings	2022-09-30	English
Loss of share certificate Regulatory Filings	2022-09-26	English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company has received an intimation from M/s Link .... Regulatory Filings	2022-09-26	English
Postal Ballot Regulatory Filings	2022-09-23	English
With reference to e-postal ballot process undertaken by Lyka Labs Limited for seeking approval of the Members for - 1. Appointment of Mr. Prashant Godha as a Director of the Company. .... Regulatory Filings	2022-09-23	English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2022 or Nehal Narendra Gandhi Regulatory Filings	2022-09-15	English
Lyka Labs Limited intimated about the postal ballot notice dated 05.09.2022 Regulatory Filings	2022-09-05	English
Postal Ballot Regulatory Filings	2022-09-05	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved; 1. .... Regulatory Filings	2022-09-05	English
Outcome of Board Meeting Regulatory Filings	2022-09-05	English
Board Meeting — Other business matters Regulatory Filings	2022-08-29	English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2022 ,inter alia, to consider and approve We wish to inform you that the meeting .... Regulatory Filings	2022-08-29	English
Price movement Regulatory Filings	2022-08-26	English
We refer to your mail of even date seeking clarification on significant increase in the volume of our security across the exchange in the recent past. In the matter, we wish to clarify .... Regulatory Filings	2022-08-25	English
Spurt in Volume Regulatory Filings	2022-08-25	English
Loss of share certificate Regulatory Filings	2022-08-22	English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company has received an intimation from M/s Link .... Regulatory Filings	2022-08-22	English
Loss of share certificate Regulatory Filings	2022-08-22	English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company has received an intimation from M/s Link .... Regulatory Filings	2022-08-22	English
Postal Ballot Regulatory Filings	2022-08-18	English
Notice is hereby given to the Members of Lyka Labs Limited, pursuant to Section 108 and 110 of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) .... Regulatory Filings	2022-08-18	English
Amalgamation/Merger Regulatory Filings	2022-08-16	English
With respect to above we wish to inform you that Lyka Exports Limited a subsidiary, is amalgamating with its holding Company w.e.f. 1st April, 2022 (Appointed Date). We provide following .... Regulatory Filings	2022-08-16	English
Reply to Clarification Sought Regulatory Filings	2022-08-16	English
Dear Sir, We are seeking approval of the shareholders through e-postal ballot voting for following business. 1. Appointment of Mr. Prashant Godha an Additional Director as a Director .... Regulatory Filings	2022-08-09	English
General updates Regulatory Filings	2022-08-09	English
Sub.: Intimation of Reconstitution of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee and Corporate Social Responsibility .... Regulatory Filings	2022-08-09	English
General updates Regulatory Filings	2022-08-09	English
The Board of Directors at its meeting held on today appointed Mr. Babulal Jain (DIN: 00016573) as an Independent Director of the Company with effect from 8th August, 2022 for a Term of .... Regulatory Filings	2022-08-09	English
In Compliance with Regulation 30 of SEBI (Listing and Obligations Disclosure Requirements) 2015, we would like to inform you that at the Board Meeting of the Company held today i.e. 8th .... Regulatory Filings	2022-08-09	English
Appointment Regulatory Filings	2022-08-09	English
In Compliance with Regulation 30 of SEBI (Listing and Obligations Disclosure Requirements) 2015, we would like to inform you that the Board has considered resignation letter of Smt. Nehal .... Regulatory Filings	2022-08-09	English
Resignation Regulatory Filings	2022-08-09	English
Appointment Regulatory Filings	2022-08-09	English
Un-audited Standalone and Consolidated Financial Results for the First Quarter ended 30th June, 2022 together with Limited Review Report (enclosed). Regulatory Filings	2022-08-08	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved Regulatory Filings	2022-08-08	English
Outcome of Board Meeting Regulatory Filings	2022-08-08	English
Annual General Meeting Regulatory Filings	2022-08-03	English
The Company convened its 43rd Annual General Meeting on 1st August, 2022 and the business mentioned in the Notice was transacted and passed with requisite majority. In this regard, we .... Regulatory Filings	2022-08-03	English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) 2015, we enclose herewith Summary Proceedings of the 43rd AGM of Lyka Labs Limited ('the Company') held .... Regulatory Filings	2022-08-02	English
Annual General Meeting Regulatory Filings	2022-08-02	English
Re-appointment Regulatory Filings	2022-08-01	English
Sub.: Intimation under Regulation 30 for Appointment and Re-Appointment of Dhara P. Shah as an Independent Director In Compliance with Regulation 30 of SEBI (Listing and Obligations .... Regulatory Filings	2022-08-01	English
Cessation Regulatory Filings	2022-08-01	English
Lyka Labs Limited would like to inform you that the tenure of Shri. Vinod S. Shanbhag (DIN: 00555709) an Independent Director of the Company has Completed at the conclusion of the 43rd .... Regulatory Filings	2022-08-01	English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve 1. Standalone and Consolidated Un-Audited .... Regulatory Filings	2022-08-01	English
Intimation of Board Meeting Regulatory Filings	2022-08-01	English
General updates Regulatory Filings	2022-07-25	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30th June, 2022 received from M/s Link .... Regulatory Filings	2022-07-25	English
Book Closure Regulatory Filings	2022-07-11	English
We wish to inform you that 43rd AGM of the Company is scheduled to be held on Monday, 01st August, 2022 at 12.15 P.M. (IST) through Video Conference /Other Audio Visual Means ('VC/OAVM'). The .... Regulatory Filings	2022-07-11	English
We wish to inform you that 43rd AGM of the Company is scheduled to be held on Monday, 01st August, 2022 at 12.15 P.M. (IST) through Video Conference /Other Audio Visual Means ('VC/OAVM'). The .... Regulatory Filings	2022-07-11	English
Closure of trading window Regulatory Filings	2022-06-30	English
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider .... Regulatory Filings	2022-06-30	English
Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2022-06-18	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2022-06-18	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved; .... Regulatory Filings	2022-06-08	English
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure on Related Party Transaction .... Regulatory Filings	2022-06-02	English
Related Party Transaction Regulatory Filings	2022-06-02	English
General updates Regulatory Filings	2022-05-31	English
With respect to above, we are pleased to inform you that the Company has made today pre payment of full and final outstanding amount of Rs.11.88 crores of RSF 1 facility and Rs.36.47 .... Regulatory Filings	2022-05-31	English
Pursuant to Regulation 24A of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019, please find enclosed copy of Annual Secretarial Compliance .... Regulatory Filings	2022-05-30	English
Annual General Meeting Regulatory Filings	2022-05-25	English
Please refer to our letter dated 20th May, 2022 wherein we have informed you about the date of Annual General Meeting as 05th August, 2022 and Book Closure period of 7 days from 29th .... Regulatory Filings	2022-05-25	English
Re-appointment Regulatory Filings	2022-05-21	English
The Board of Directors at its meeting held on today re-appointed Mrs. Dhara P. Shah (Din: 07530998) as an Independent Director of the Company with effect from 4th August, 2022 for a Second .... Regulatory Filings	2022-05-21	English
Financial Result Updates Regulatory Filings	2022-05-21	English
Outcome of Board Meeting Regulatory Filings	2022-05-20	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved Regulatory Filings	2022-05-20	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved Regulatory Filings	2022-05-20	English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2022 for Narendra Ishwarlal Gandhi Regulatory Filings	2022-05-20	English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2022 for Kunal Narendra Gandhi Regulatory Filings	2022-05-20	English
Board Meeting — Financial results/Other business matters Regulatory Filings	2022-05-13	English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 ,inter alia, to consider and approve We wish to inform you that the meeting .... Regulatory Filings	2022-05-13	English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2022-04-29	English
In compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 12th April, 2022 .... Regulatory Filings	2022-04-19	English
General updates Regulatory Filings	2022-04-14	English
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate, duly signed by Authorized Signatory .... Regulatory Filings	2022-04-14	English
In compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 12th April, 2022 .... Regulatory Filings	2022-04-14	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31 March, 2022 received form M/s Link .... Regulatory Filings	2022-04-14	English
Price movement Regulatory Filings	2022-04-12	English
We refer to your mail dated 11th April, 2022, seeking clarification on the price movement of our shares. In the matter, we wish to inform you that the price movement of our shares is regulated .... Regulatory Filings	2022-04-12	English
Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2022-04-06	English
Closure of trading window Regulatory Filings	2022-03-31	English
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider .... Regulatory Filings	2022-03-31	English
Post Offer Public announcement Regulatory Filings	2022-02-25	English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement to the Shareholders of Lyka Labs Ltd ("Target Company"). Regulatory Filings	2022-02-25	English
Loss of share certificate Regulatory Filings	2022-02-24	English
Loss of share certificate Regulatory Filings	2022-02-24	English
Loss of share certificate Regulatory Filings	2022-02-24	English
Loss of share certificate Regulatory Filings	2022-02-24	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd Regulatory Filings	2022-02-24	English
Loss of share certificate Regulatory Filings	2022-02-21	English
Intimation regarding loss of Share Certificates under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. Regulatory Filings	2022-02-21	English
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 03, 2022 for Kunal Narendra gandhi Regulatory Filings	2022-02-03	English
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 03, 2022 for Kunal Narendra gandhi Regulatory Filings	2022-02-03	English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement for the attention of the Equity Shareholders of Lyka Labs Ltd ("Target Company"). Regulatory Filings	2022-01-25	English
Open Offer Regulatory Filings	2022-01-25	English
Financial Result Updates Regulatory Filings	2022-01-20	English
Outcome of Board Meeting Regulatory Filings	2022-01-20	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held on 20th January, 2022 considered and approved; .. Regulatory Filings	2022-01-20	English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held on 20th January, 2022 considered and approved; .. Regulatory Filings	2022-01-20	English
Corrigendum Regulatory Filings	2022-01-20	English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement cum Corrigendum to Detailed Public Statement (DPS) for the attention of the Equity .... Regulatory Filings	2022-01-20	English
Updates Regulatory Filings	2022-01-19	English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of Committee of Independent Directors (IDC) on the Open Offer to the Equity Shareholders .... Regulatory Filings	2022-01-19	English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Shareholders of Lyka Labs Ltd ("Target Company"). Regulatory Filings	2022-01-19	English
Updates Regulatory Filings	2022-01-19	English
Updates Regulatory Filings	2022-01-14	English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31st December, 2021 received form M/s .... Regulatory Filings	2022-01-14	English
Board Meeting — Financial Results Regulatory Filings	2022-01-13	English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2022 ,inter alia, to consider and approve This is to inform you that the meeting .... Regulatory Filings	2022-01-13	English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 04, 2022 for Kunal Narendra Gandhi Regulatory Filings	2022-01-04	English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 04, 2022 for Kunal Narendra Gandhi Regulatory Filings	2022-01-04	English

Filings by year

2026 44 filings
2025 162 filings
2024 202 filings
2023 187 filings
2022 141 filings
2021 102 filings
2020 105 filings
2019 99 filings
2018 28 filings
2017 31 filings
2016 22 filings
2015 38 filings
2014 25 filings
2013 11 filings
2012 4 filings
2011 3 filings
2010 1 filing